These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antidiarrheal efficacy of a quinazolin CFTR inhibitor on human intestinal epithelial cell and in mouse model of cholera. Patanayindee J, Muanprasat C, Soodvilai S, Chatsudthipong V. Indian J Pharmacol; 2012 Mar 16; 44(5):619-23. PubMed ID: 23112425 [Abstract] [Full Text] [Related]
7. Calcium/calcimimetic via calcium-sensing receptor ameliorates cholera toxin-induced secretory diarrhea in mice. Tang LQ, Fraebel J, Jin S, Winesett SP, Harrell J, Chang WH, Cheng SX. World J Gastroenterol; 2024 Jan 21; 30(3):268-279. PubMed ID: 38314127 [Abstract] [Full Text] [Related]
8. Inhibition of cAMP-activated intestinal chloride secretion by diclofenac: cellular mechanism and potential application in cholera. Pongkorpsakol P, Pathomthongtaweechai N, Srimanote P, Soodvilai S, Chatsudthipong V, Muanprasat C. PLoS Negl Trop Dis; 2014 Sep 21; 8(9):e3119. PubMed ID: 25188334 [Abstract] [Full Text] [Related]
9. Inhibition of CFTR-mediated intestinal chloride secretion by a fungus-derived arthropsolide A: Mechanism of action and anti-diarrheal efficacy. Akrimajirachoote N, Satitsri S, Sommart U, Rukachaisirikul V, Muanprasat C. Eur J Pharmacol; 2020 Oct 15; 885():173393. PubMed ID: 32712094 [Abstract] [Full Text] [Related]
10. Lubiprostone is non-selective activator of cAMP-gated ion channels and Clc-2 has a minor role in its prosecretory effect in intestinal epithelial cells. Oak AA, Chu T, Yottasan P, Chhetri PD, Zhu J, Du Bois J, Cil O. Mol Pharmacol; 2022 Jun 09; 102(2):106-15. PubMed ID: 35680165 [Abstract] [Full Text] [Related]
11. Adenylyl Cyclase 6 Expression Is Essential for Cholera Toxin-Induced Diarrhea. Fenton RA, Murali SK, Kaji I, Akiba Y, Kaunitz JD, Kristensen TB, Poulsen SB, Dominguez Rieg JA, Rieg T. J Infect Dis; 2019 Oct 22; 220(11):1719-1728. PubMed ID: 30624615 [Abstract] [Full Text] [Related]
12. Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins. Cil O, Phuan PW, Gillespie AM, Lee S, Tradtrantip L, Yin J, Tse M, Zachos NC, Lin R, Donowitz M, Verkman AS. FASEB J; 2017 Feb 22; 31(2):751-760. PubMed ID: 27871064 [Abstract] [Full Text] [Related]